Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Leff

Showing results (141-150 of 168) with videos related to

Pageof 17
Sort By:
Lancet (London, England)|March 27, 1993
Serum antioxidants as predictors of adult respiratory distress syndrome in patients with sepsisJ A Leff, P E Parsons, C E Day, et al.
The American Journal of Physiology|January 1, 1994
Interleukin-1-induced lung neutrophil accumulation and oxygen metabolite-mediated lung leak in ratsJ A Leff, J W Baer, M E Bodman, et al.
Sexually Transmitted Diseases|August 15, 2014
The cost of implementing rapid HIV testing in sexually transmitted disease clinics in the United StatesAshley A Eggman, Daniel J Feaster, Jared A Leff, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 24, 2024
Economic Evaluations of Establishing Opioid Overdose Prevention Centers in 12 North American Cities: A Systematic ReviewCzarina N Behrends, Jared A Leff, Weston Lowry, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 3, 1999
The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthmaZ Diamant, D C Grootendorst, M Veselic-Charvat, et al.
American Journal of Respiratory and Critical Care Medicine|January 31, 2014
All-cause mortality rate in patients with idiopathic pulmonary fibrosis. Implications for the design and execution of clinical trialsTalmadge E King, Carlo Albera, Williamson Z Bradford, et al.
Drug and Alcohol Dependence|February 26, 2018
Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programsBruce R Schackman, Sarah Gutkind, Jake R Morgan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2019
Cost-effectiveness of Hepatitis C Virus Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment ProgramsSarah Gutkind, Bruce R Schackman, Jake R Morgan, et al.
Endocrine|December 29, 1998
Prolactin-regulated apoptosis of Nb2 lymphoma cells: pim-1, bcl-2, and bax expressionJ S Krumenacker, D J Buckley, M A Leff, et al.
Addiction (Abingdon, England)|May 5, 2021
Cost-effectiveness implications of increasing the efficiency of the extended-release naltrexone induction process for the treatment of opioid use disorder: a secondary analysisSean M Murphy, Philip J Jeng, Kathryn E McCollister, et al.
Pageof 17

Showing results (141-150 of 168) with videos related to

Sort By:
Pageof 17
Lancet (London, England)|March 27, 1993
Serum antioxidants as predictors of adult respiratory distress syndrome in patients with sepsisJ A Leff, P E Parsons, C E Day, et al.
The American Journal of Physiology|January 1, 1994
Interleukin-1-induced lung neutrophil accumulation and oxygen metabolite-mediated lung leak in ratsJ A Leff, J W Baer, M E Bodman, et al.
Sexually Transmitted Diseases|August 15, 2014
The cost of implementing rapid HIV testing in sexually transmitted disease clinics in the United StatesAshley A Eggman, Daniel J Feaster, Jared A Leff, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 24, 2024
Economic Evaluations of Establishing Opioid Overdose Prevention Centers in 12 North American Cities: A Systematic ReviewCzarina N Behrends, Jared A Leff, Weston Lowry, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 3, 1999
The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthmaZ Diamant, D C Grootendorst, M Veselic-Charvat, et al.
American Journal of Respiratory and Critical Care Medicine|January 31, 2014
All-cause mortality rate in patients with idiopathic pulmonary fibrosis. Implications for the design and execution of clinical trialsTalmadge E King, Carlo Albera, Williamson Z Bradford, et al.
Drug and Alcohol Dependence|February 26, 2018
Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programsBruce R Schackman, Sarah Gutkind, Jake R Morgan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2019
Cost-effectiveness of Hepatitis C Virus Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment ProgramsSarah Gutkind, Bruce R Schackman, Jake R Morgan, et al.
Endocrine|December 29, 1998
Prolactin-regulated apoptosis of Nb2 lymphoma cells: pim-1, bcl-2, and bax expressionJ S Krumenacker, D J Buckley, M A Leff, et al.
Addiction (Abingdon, England)|May 5, 2021
Cost-effectiveness implications of increasing the efficiency of the extended-release naltrexone induction process for the treatment of opioid use disorder: a secondary analysisSean M Murphy, Philip J Jeng, Kathryn E McCollister, et al.
Pageof 17